About Genzyme
Genzyme is a company based in Boston (United States) founded in 1996 was acquired by Sanofi in February 2011.. Genzyme has completed 2 acquisitions, including Bioenvision and Ilex Oncology. Genzyme offers products and services including Vaccines, Medicines for Immunology, Neurology Medicines, and Consumer Healthcare Products.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genzyme India Private Limited
- Date of Incorporation 21 Nov, 2007
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$65.35 K (USD)-32.22as on Mar 31, 2017
-
Net Profit
$24.43 K (USD)-23.31as on Mar 31, 2017
-
EBITDA
$-20.73 K (USD)40.38as on Mar 31, 2017
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Bioenvision
& 1 more
-
Acquired by
Sanofi
(Feb 16, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genzyme
Genzyme offers a comprehensive portfolio of products and services, including Vaccines, Medicines for Immunology, Neurology Medicines, and Consumer Healthcare Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products that prevent diseases like influenza and meningitis.
Treatments targeting immune system disorders and related conditions.
Drugs for neurological conditions such as rare diseases and disorders.
Items for allergy, cold relief, and digestive health management.
Funding Insights of Genzyme
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genzyme
Genzyme has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sanofi. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical and nutraceutical products are developed across seven therapeutic areas.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genzyme
Genzyme has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Bioenvision and Ilex Oncology. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Monoclonal antibody therapies for B-cell chronic lymphocytic leukemia are developed.
|
2000 | ||||
|
Acquisition, development, and marketing of compounds and technologies for the treatment of cancer
|
1996 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Genzyme
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genzyme Comparisons
Competitors of Genzyme
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genzyme
Frequently Asked Questions about Genzyme
When was Genzyme founded?
Genzyme was founded in 1996.
Where is Genzyme located?
Genzyme is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
What is the annual revenue of Genzyme?
Annual revenue of Genzyme is $65.35K as on Mar 31, 2017.
What does Genzyme do?
Genzyme Corporation is a fully owned subsidiary of Sanofi. It is focused on rare genetic diseases known as lysosomal storage disorders (LSDs). They have also expanded through both in-house development and strategic acquisitions and partnerships to other disease areas such as thyroid cancer and multiple sclerosis. The first orphan-drug for Genzyme that FDA approved was Ceredase, a drug for treating Gaucher disease. Other important drugs made by Genzyme are Renagel, used in treatment of dialysis patients, and Fabrazyme, used to treat patients with Fabrys disease. Other products in development are Tolevamer for Clostridium difficile colitis and Campath for Chronic lymphocytic leukemia.
What products or services does Genzyme offer?
Genzyme offers Vaccines, Medicines for Immunology, Neurology Medicines, and Consumer Healthcare Products.
How many acquisitions has Genzyme made?
Genzyme has made 2 acquisitions, including Bioenvision, and Ilex Oncology.
Who are Genzyme's investors?
Genzyme has 1 investor. Key investors include Sanofi.